BioCapital Europe Company of the Year award goes to Prosensa

- Amsterdam, March 26, 2015. At the BioCapital Europe conference being held today in Amsterdam, Hans Schikan, CEO Prosensa, was presented with the BioCapital Company of the Year award by Martijn Kleijwegt, Managing Partner at LSP. Investors and industry executives voted for Prosensa to receive this award. Prosensa’s lead program focuses on the development of novel innovative treatments for a rare genetic condition, Duchenne Muscular Dystrophy (DMD).

Internationalisation Guide

- Als klein land is Nederland aangewezen op het buitenland. Ook zorgvernieuwers hebben veel te winnen bij internationalisering. Maar hoe doe je dat? Met wie? Waar moet je beginnen? En welke concrete stappen moet je maken? De vandaag verschenen InternationaliseringsGIDS brengt kennis, ervaringen, uitdagingen en suggesties bij elkaar van zorgvernieuwers die over de grenzen heen kijken.

Dutch Biotech Company T-Cell Factory Acquired by Kite Pharma

- T-Cell Factory B.V. (TCF), a privately held Dutch company and former participant of the Venture Challenge, has been acquired by Kite pharma, INc (KITE). KITE is a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products based on CAR and TCR gene therapy platforms for the treatment of cancer.

Treeway is melting the Ice Buckets!

- Treeway is melting the Ice Buckets and offers talented master / PhD students a once in a lifetime study opportunity!

Health~Holland Update, March 2015

- We are happy to present to you the first issue of our bimonthly news magazine, the Health~Holland Update.

Start Projects Life Sciences & Health for Development fund

- Vanuit het Fonds Life Sciences and Health for Development (LS&H4D) zijn begin 2015 9 projecten van start gegaan. De projecten verhogen de gezondheidsstatus van de armere bevolkingsgroepen in ontwikkelingslanden met innovatieve gezondheidstechnologieën.

Report Healthcare export top

- During the recent 'Top Zorg Export' in the Ridderzaal in The Hague, more than 150 representatives from all sections of the LSH sector discussed the possibilities to improve our chances abroad. In order to have international success, it is crucial to represent the Netherlands as a whole, instead of every company or institution for themselves. Through good collaboration and the exchange of experiences and contacts in other countries more doors can be opened and chances can be seized.

Systems Medicine / Personalized Medicine : The CASyM / BIOVISION call for pitches on R&D collaborative projects ideas is now open.

- Submit your R&D collaborative project idea in the systems Medicine / Personalized Medicine field, and gain visibility both during the CASyM’s event of Tuesday April 14th 2015 in Lyon, and during Biovision on April 15th & 16th April 2015 in Lyon.

Lead Pharma to Partner with Sanofi on Development of Treatments for Autoimmune Diseases

- Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of autoimmune diseases and cancer, today announced that it has entered into a research collaboration and license agreement with Sanofi to discover, develop and commercialize small molecule therapies directed against the nuclear hormone receptor ROR gamma (t) to treat a broad range of autoimmune disorders, including common diseases such as rheumatoid arthritis and inflammatory bowel disease.

ZonMw grants five projects in LSH '2Treat' call

- Kennisinstituten, bedrijfsleven en gezondheidsfondsen gaan samenwerken in 5 onderzoeksprojecten op het gebied van Regenerative Geneeskunde en Moleculaire Diagnostiek / Pharmacotherapie.